Atlas Trials

A Study to Compare the Efficacy and Safety of GZR102 Injection and GZR18 Injection in Type 2 Diabetes Mellitus

Clinical trial NCT07055386 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07055386
Sponsor
Gan & Lee Pharmaceuticals.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus (T2DM)
Start date
2025-08-07
Primary completion
2026-06-28
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.